Catalyst Wire Dossier Catalyst Wire Dossier

Actemra (tocilizumab)

tocilizumab · Roche/Genentech
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Actemra (tocilizumab), covering 2010-06-11 to 2025-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Treatment for Giant Cell Arteritis With Tocilizumab and 8 as Compared to 26 Weeks of Prednisone [Phase 3]

See pricing